Science and research

The role of C-Terminal Nucleophosmin Mutations in AML

Specific C-terminal mutations in the gene for nucleophosmin 1 (NPM1) are found in about 30% of patients with acute myelogenous leukemia and are associated with better prognosis. The mutations are known to induce changes in the protein intracellular localization which presumably lead to a partial loss of function.

However, the role of the mutated NPM in leukemogenesis is still unknown. We focus on detailed characterization of changes in NPM localization, oligomerization and protein-protein complex formation due to different C-terminal mutations that are found in AML patients.

Quick contact

Head of Science and Research Division
Tel:+420 221 977 208

Deputy head of Science and Research Division
Tel:+420 221 977 269
Tel:+420 221 977 364

Tel:+420 221 977 247

Opening hours

Mo – Fr: 7:00–18:00
Weekends: 9:00–13:00

Mo – Fr: 7:00–10:30

Inpatient department
Mo – Fr: 13:00–18:00

ICU and Transplant unit
Mo – Fr: 14:00–17:00

How to find us


Ústav hematologie a krevní transfuze
(​Institute of Hematology and Blood Transfusion)

U Nemocnice 2094/1
128 00 Praha 2

The nearest underground station: Karlovo náměstí (line B)

The nearest tram station: Karlovo náměstí (10, 16, 22), Moráň (3, 6, 10, 16, 18, 24)

The nearest bus station: U Nemocnice (148), Karlovo náměstí (176)

How to get here